Northern Trust’s ARK Genomic Revolution ETF ARKG Stock Holding History

Northern Trust’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-18,582	Closed	-$585K	–	4713
2022 Q2	$585K	Buy	+18,582	New	+$650K	﹤0.01%	3492
2022 Q1	–	Sell	-4,898	Closed	-$300K	–	4748
2021 Q4	$300K	Sell	4,898 -1,240	-20%	-$85.7K	﹤0.01%	4019
2021 Q3	$459K	Buy	6,138 +378	+7%	+$31.7K	﹤0.01%	3795
2021 Q2	$533K	Sell	5,760 -7,004	-55%	-$595K	﹤0.01%	3685
2021 Q1	$1.13M	Buy	+12,764	New	+$1.27M	﹤0.01%	3531

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Northern Trust's ARKG Position: Q3 2022 in Review

Northern Trust sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2022, closing a stake of 18,582 shares — an estimated $585K sold.

Northern Trust first reported a position in ARKG in Q1 2021 and held it in 5 quarters. The position peaked at $1.13M in Q1 2021. 311 funds tracked by Wall St. Rank hold ARKG as of Q3 2022.

Northern Trust reported no remaining ARK Genomic Revolution ETF position as of Q3 2022 after selling out during the quarter.
Northern Trust sold 18,582 ARK Genomic Revolution ETF shares in Q3 2022, an estimated $585K.
Northern Trust first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 5 quarters.
Northern Trust's ARK Genomic Revolution ETF position peaked at $1.13M in Q1 2021.
311 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2022.

Based on Northern Trust's 13F filing for Q3 2022, filed 14 Nov 2022.